Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percen... (2010 offset by reductions in the tax pro...)

HOME >> MEDICINE >> TECHNOLOGY

Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21

Date:1/24/2011

2010, offset by reductions in the tax provision in the fourth quarter of 2009 as a result of changes in revenue and expense mix.

For 2010, the adjusted tax rate was 18.8 percent compared to 16.9 percent for 2009. The increase in the full year adjusted tax rate was due primarily to the favorable impact in 2009 of settling IRS and California tax audits for prior years. During the fourth quarter of 2010, Amgen repurchased approximately 20 million shares of common stock at a total cost of $1.1 billion. For 2010, Amgen repurchased approximately 66 million shares of common stock at a total cost of $3.8 billion. The Company currently has $2.2 billion remaining under its authorized stock repurchase program.

Average diluted shares for adjusted EPS for the fourth quarter of 2010 were 946 million versus 1,012 million for the fourth quarter of 2009 and 965 million for the full year 2010 versus 1,021 million for the full year 2009.

Capital expenditures for the fourth quarter of 2010 were approximately $182 million versus $144 million in the fourth quarter of 2009. For 2010, capital expenditures were $580 million versus $530 million in 2009. Operating cash flow for 2010 decreased 8 percent to approximately $5.8 billion versus approximately $6.3 billion in 2009 due primarily to timing differences in tax payments. Worldwide cash and marketable securities were $17.4 billion and adjusted outstanding debt was $13.7 billion as of Dec. 31, 2010. The Company’s adjusted outstanding debt excludes the impact of a change in accounting for the carrying values of its convertible debt. The Company’s outstanding debt presented in accordance with GAAP was $13.4 billion as of Dec. 31, 2010.

2011 Guidance The Company expects total revenue for 2011 to be in the range of $15.1 billion to $15.5 billion. Amgen expects 2011 adjusted EPS to be in the range of $5.00 to $5.20, excluding stock opti
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Related medicine technology :

1. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
2. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
3. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
4. PLC Systems Reports Fourth Quarter 2007 Results
5. Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results
6. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
7. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
8. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
9. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
10. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
11. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments

Post Your Comments:

(Date:5/21/2013)... 21, 2013 Reportlinker.com announces that ... in its catalogue: ... Optical Coherence Tomography (OCT) ... OBJECTIVES BCC,s ... offer synopsis of the current and future ...

(Date:5/21/2013)... and TARRYTOWN, N.Y. , May ... SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced ... published online the positive Phase 2a study results of ... is an investigational monoclonal antibody targeting the alpha subunit ... signaling of both IL-4 and IL-13, drivers of Th2 ...

(Date:5/21/2013)... 21, 2013 Healthcare organizations expanding into emerging markets ... , India and ... no shortcuts. This is proving particularly challenging, considering the ... must change the dialogue around BRIC, as it is ... and building regional partnerships to build a sustainable business. ...

Breaking Medicine Technology:Global Markets and Technologies for Optical Coherence Tomography (OCT) 2 Global Markets and Technologies for Optical Coherence Tomography (OCT) 3 Global Markets and Technologies for Optical Coherence Tomography (OCT) 4 Global Markets and Technologies for Optical Coherence Tomography (OCT) 5 Global Markets and Technologies for Optical Coherence Tomography (OCT) 6 Global Markets and Technologies for Optical Coherence Tomography (OCT) 7 Global Markets and Technologies for Optical Coherence Tomography (OCT) 8 Global Markets and Technologies for Optical Coherence Tomography (OCT) 9 Global Markets and Technologies for Optical Coherence Tomography (OCT) 10 Global Markets and Technologies for Optical Coherence Tomography (OCT) 11 Global Markets and Technologies for Optical Coherence Tomography (OCT) 12 Global Markets and Technologies for Optical Coherence Tomography (OCT) 13 Global Markets and Technologies for Optical Coherence Tomography (OCT) 14 Global Markets and Technologies for Optical Coherence Tomography (OCT) 15 Global Markets and Technologies for Optical Coherence Tomography (OCT) 16 Global Markets and Technologies for Optical Coherence Tomography (OCT) 17 Global Markets and Technologies for Optical Coherence Tomography (OCT) 18 Global Markets and Technologies for Optical Coherence Tomography (OCT) 19 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7 Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 2 Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 3 Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 4

[0] Global Markets and Technologies for Optical Coherence Tomography (OCT)[0] Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine [0] Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets

... NEW YORK, Sept. 28 Delcath Systems, Inc. (Nasdaq: ... the William Blair Emerging Growth Stock Conference on Tuesday, October ... Mr. David McDonald, Chief Financial Officer, will provide an overview ... Attendance at this conference is by invitation only. Delcath ...

... BOTHELL, Wash., Sept. 27 SCOLR Pharma, Inc. (NYSE ... Johnson has been appointed as the Chairman of its ... remain a member of the Board. ... of Matrixx Initiatives, Inc. Under Johnson,s leadership, Matrixx successfully ...

Cached Medicine Technology:Delcath to Present at the William Blair Emerging Growth Stock Conference 2 SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director 2 SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director 3

Delcath to Present at the William Blair Emerging Growth Stock Conference SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director

(Date:5/21/2013)... Mecklenburg EMS Agency (Medic) and ... free Community Wellness Fair to educate the public on health ... held on Wednesday, May 22, 2013 from 4:00 pm until ... Old Mallard Creek Road, Charlotte, NC 29262). , ... the Mecklenburg County Department of Social Services are ...

(Date:5/21/2013)... AZ (PRWEB) May 21, 2013 ... and inventors who want to develop their ideas ... summer program. , The university is recruiting ... revolutionary new “formation space” that provides early-stage entrepreneurs ... While AREA48 is open to anyone, ASU is ...

(Date:5/21/2013)... 2013 Diversity Focus, a non-profit organization ... all residents in the Creative Corridor region, is releasing ... a news conference on Thursday, May 23rd at 10:30 ... in 2008. , The survey is a ... support efforts that attract, nurture and retain people of ...

(Date:5/21/2013)... two proteins, thrombospondin-1 and prosaposin, play in discouraging ... a five-amino acid fragment of prosaposin that significantly ... breast and lung cancer. The findings suggest that ... a variety of cancers. , The study ... Children,s Hospital, Vivek Mittal, PhD, at Weill Cornell ...

(Date:5/21/2013)... York, New York (PRWEB) May 21, 2013 ... Vinci surgery robot lawsuit is nearing its conclusion ... According to Bloomberg.com, during closing statements yesterday, an attorney ... dealership, alleging the company wanted to tie sales and ... do all the training to keep control of surgeons, ...

Breaking Medicine News(10 mins):Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2 Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2 Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3 Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4 Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2 Health News:Changing cancer's environment to halt its spread 2 Health News:Changing cancer's environment to halt its spread 3 Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2 Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3 Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4

[0] Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives [0] ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors [0] Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m.[0] Changing cancer's environment to halt its spread [0] Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial

... , ROCHESTER, N.Y., Aug. 12 VirtualScopics, Inc. (Nasdaq: ... announced its financial results for the quarter and six months ended June 30, ... Revenues for the second quarter of 2009 increased 47% to $2.5 ... Gross profit for the second quarter of 2009 increased 96% ...

... NEWARK, N.J., Aug. 12 BioNeutral Group, Inc. ("BioNeutral") (OTC ... that ATS Labs using the EPA required AOAC Sporicidal Test with Ygiene(TM) ... over one million live Clostridium ... time frame - performance which is up to 75 times faster than ...

... With the recent increase in the tobacco tax, many Floridians ... times - do they pay the extra dollar per pack or ... The Florida Quitline (1-877-U-CAN-NOW) is here to help by offering free ... According to Kim Berfield, Deputy Secretary of the Florida Department of ...

... , , , , ... a leading provider of Linux-bas e d ... Systems, a national health care management company, has deployed Arkeia Network Backup. ... Goold has realized dramatic improvements in backup performance and in backup administration. ...

... August 12 Fountain Healthy Aging,Inc. announced on August 12 ... Partners and Oak Resources Limited which provides the Company,with a ... the,agreement, Fountain has the right to draw down from the ... a term of 24 months. The,first tranche investment of $1,000,000 ...

... , WESTFIELD, Ind., Aug. 12 ... company for healthcare providers, announced the successful "Stage 6" designation ... hospital located in Silver City, New Mexico. maxIT assisted the ... IT consultants to support the implementation of several HIS modules. ...

VirtualScopics, Inc. Reports a Record Breaking Quarter BioNeutral's Ygiene(TM) Achieves World's Fastest Kill Time With a 100% Total Spore Eradication Verified In Independent Sporicidal/Sterilant Test The Time To Quit Is Now -- Free NRT Is Available Goold Health Systems Accelerates Backups by 5-times Using Arkeia Network Backup Fountain Healthy Aging Inc Announces $5,000,000 Equity Line Of Credit Investment Secured maxIT Assists Medical Center to Achieve Prestigious Stage 6 Recognition

Custom Pediatric Nebulizer Assembly W/Tubing...

... Patients over the age of 3 can choose ... STAR®. The same design principle applies to both:, ... and minimize aerosol output when the patient exhales ... optimum size to leave the nebulizer. The result ...

... medication nebulizer achieves optimum lung penetration for ... range is 1.04-1.10 µ at 6-8 LPM. ... outlet., ,As the world leader in ... the assurance of proven technology by offering ...

... Portex® medication nebulizers offer a spill-proof design ... to a 45° angle. All medical nebulizers ... wide variety of configurations are available., ... , ,Portex® medication nebulizers feature consistently ...

Medicine Products:

Pediatric Custom Nebulizers PARI LC STAR® Reusable Nebulizer Raindrop® Medication Nebulizer - Pediatric Aerosol Mask & Tubing 007767 Medication Nebulizer Kit